MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
August 5, 2020

Support Tool Predicts Endoscopic Healing Among Ulcerative Colitis Patients on Infliximab

By Alexa Josaphouitch, /alert Contributor
A group of researchers developed and validated a clinical decision support tool that uses data on infliximab clearance and baseline patient and disease measures to identify patients most likely to have endoscopic healing with infliximab therapy...
Support Tool Predicts Endoscopic Healing Among Ulcerative Colitis Patients on Infliximab
August 4, 2020

FDA Approves Brigatinib as First-Line Lung Cancer Treatment for ALK+ Patients

By Adam Hochron
The FDA has approved brigatinib for adults with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer, according to a release from the manufacturer...
 
FDA Approves Brigatinib as First-Line Lung Cancer Treatment for ALK+ Patients
August 2, 2020

NDA Submitted for Triple-Class Refractory Multiple Myeloma Treatment

By Adam Hochron
A New Drug Application has been submitted to the FDA seeking accelerated approval for melflufen, a new treatment for some patients with multiple myeloma...
NDA Submitted for Triple-Class Refractory Multiple Myeloma Treatment
August 1, 2020

Hypertension Trends Show Increased Mortality Rate Over Last Decade

By Dave Quaile, /alert Contributor
A research letter recently published in Hypertension, has shown an increase in total hypertension-related CVD deaths and overall AAMR for hypertension-related CVD between 2000 and 2018, despite targeted public health efforts...
Hypertension Trends Show Increased Mortality Rate Over Last Decade
July 29, 2020

New AML Treatment Could Help Reduce Side Effects Without Affecting Efficacy

By Adam Hochron
An investigational nanomedicine developed for the treatment of AML has tested well during clinical trials at centers across Europe...
New AML Treatment Could Help Reduce Side Effects Without Affecting Efficacy
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

REFILE-Predicted albumin-creatinine ratio performs well for CKD screening, staging and prognosis

(In para 3, changes CSK to CKD, in story originally published July 13.) By Megan Brooks (Reuters Health) - Researchers with the Chronic Kidney Disease Prognosis Consortium have developed equations to Read More »

Brain-computer interface training reduces phantom-limb pain

By Will Boggs MD NEW YORK (Reuters Health) - Brain-computer interface (BCI) to control an image of a phantom hand reduces phantom-limb pain, according to results from a crossover trial. "BCI training Read More »

UPDATE 1-Second COVID wave 'highly likely' to hit France this year, scientists say

(Adds Paris considering making masks compulsory, Macron quote) By Reuters Staff PARIS (Reuters) - A second wave of the coronavirus epidemic is highly likely to hit France in the autumn or winter, the Read More »

UPDATE 1-UK risks twice-as-big second COVID wave without better testing, study finds

(Adds details, further government comment) By Reuters Staff LONDON (Reuters) - Britain risks a second wave of COVID-19 this winter twice as large as the initial outbreak if it reopens schools Read More »

Radiotherapy improves overall survival in metastatic nasopharyngeal carcinoma

By Will Boggs MD NEW YORK (Reuters Health) - Locoregional radiotherapy added to chemotherapy improves overall survival in patients with de novo metastatic nasopharyngeal carcinoma (mNPC), according to Read More »

Acetaminophen use linked to false-positive test for chronic granulomatous disease

By Anne Harding NEW YORK (Reuters Health) - Recent acetaminophen use can lead to a false positive result on the dihydrorhodamine (DHR) test, new findings show. "Taking acetaminophen may affect the Read More »

Rosuvastatin myotoxicity can emerge after initiating canagliflozin

By Reuters Staff NEW YORK (Reuters Health) - Rosuvastatin myotoxicity can develop after initiation of treatment with canagliflozin, a sodium-glucose cotransporter-2 inhibitor, according to a new case Read More »

What to do about interference between maternal pertussis vaccination, infant's DTwP shot

By Reuters Staff NEW YORK (Reuters Health) - Health providers should pay extra attention to infants with signs of pertussis given the potential interaction between maternal vaccination for the disease Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information